Quality of care assessment in chronic liver disease
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Randomized, controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
Myung Han Hyun, Sang Mi Chung – 20 January 2015
Valproic acid‐induced hepatotoxicity in alpers syndrome is associated with mitochondrial permeability transition pore opening‐dependent apoptotic sensitivity in an induced pluripotent stem cell model
Shengbiao Li, Jingyi Guo, Zhongfu Ying, Shen Chen, Liang Yang, Keshi Chen, Qi Long, Dajiang Qin, Duanqing Pei, Xingguo Liu – 20 January 2015 – Valproic acid (VPA) is widely used to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy, but potentially causes idiosyncratic liver injury. Alpers‐Huttenlocher syndrome (AHS), a neurometabolic disorder caused by mutations in mitochondrial DNA polymerase gamma (POLG), is associated with an increased risk of developing fatal VPA hepatotoxicity.
Replay
Chunping Wang, Ke‐Qin Hu, Yongping Yang – 20 January 2015
Hospital readmissions for decompensated cirrhosis
Michael L. Volk – 20 January 2015 – Watch a video presentation of this article
Overview of health care delivery and policy research in hepatology and liver transplantation
Jayant A. Talwalkar – 20 January 2015 – Watch a video presentation of this article
Health disparities in diagnosis and treatment of hepatocellular carcinoma
Amy K. Kim, Amit G. Singal – 20 January 2015 – Watch a video presentation of this article
Health disparities in diagnosis and treatment of hepatocellular carcinoma
Amy K. Kim, Amit G. Singal – 20 January 2015 – Watch a video presentation of this article
Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload
Christine E. McLaren, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, James C. Barton, Paul C. Adams, Justin B. Goh, Cameron J. McDonald, Lawrie W. Powell, Lyle C. Gurrin, Katrina J. Allen, Deborah A. Nickerson, Tin Louie, Grant A. Ramm, Gregory J. Anderson, Gordon D.
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5‐year experience
Naftali Presser, Cristiano Quintini, Cynthia Tom, Weiping Wang, Qiang Liu, Teresa Diago‐Uso, Masato Fujiki, Charles Winans, Dympna Kelly, Federico Aucejo, Koji Hashimoto, Bijan Eghtesad, Charles Miller – 20 January 2015 – Severe portal hyperperfusion (PHP) after liver transplantation has been shown to cause intrahepatic arterial vasoconstriction secondary to increased adenosine washout (hepatic artery buffer response). Clinically, posttransplant PHP can cause severe cases of refractory ascites and hydrothorax.